We decided to focus on the NDRG4 gene due to its recent validation as an epigenetic biomarker for cancer screening.22 In silico analysis of the NDRG4 promoter region revealed a canonical CpG island extending from nucleotide −556 to +869 relative to the NDRG4 TSS (Fig. 1a). Here, NDRG4 is linked to cancer.